Victory Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.53M | Sell |
138,368
-119,782
| -46% | -$5.65M | ﹤0.01% | 1231 |
|
|
2025
Q1 | $10.1M | Buy |
258,150
+79,649
| +45% | +$3.11M | 0.01% | 1039 |
|
|
2024
Q4 | $9.67M | Sell |
178,501
-39,338
| -18% | -$2.13M | 0.01% | 1094 |
|
|
2024
Q3 | $11M | Buy |
217,839
+43,157
| +25% | +$2.18M | 0.01% | 1078 |
|
|
2024
Q2 | $7.68M | Buy |
174,682
+24,037
| +16% | +$1.06M | 0.01% | 1158 |
|
|
2024
Q1 | $7.57M | Sell |
150,645
-3,962
| -3% | -$199K | 0.01% | 1138 |
|
|
2023
Q4 | $9.34M | Sell |
154,607
-28,370
| -16% | -$1.71M | 0.01% | 1079 |
|
|
2023
Q3 | $10.4M | Buy |
182,977
+162,027
| +773% | +$9.24M | 0.01% | 998 |
|
|
2023
Q2 | $1.07M | Buy |
+20,950
| New | +$1.07M | ﹤0.01% | 1640 |
|